Skip to main content

Sinopharm finally publishes Covid-19 vaccine trial data: interim Phase 3 results suggest two products have efficacy rates well above 50 per cent but there is little data on the elderly and other vulnerable groups https://ift.tt/3vxT8xA https://ift.tt/3ia82Gv https://ift.tt/3ia82Gv https://ift.tt/3yM4csE

https://ift.tt/3ia82Gv

Submitted May 27, 2021 at 08:47PM by DoremusJessup https://ift.tt/3yM4csE DoremusJessup
Labels:

Comments

Post a Comment

Popular posts from this blog

Humans and wildlife face escalating risks from potentially harmful chemical because production of new compounds outstripping capacity to test toxicity. Warning from panel of UK experts behind review of scientific research on effects of hormone-disrupting chemicals leaching into ecosystems. https://ift.tt/2GLdSw5 https://ift.tt/2EyMZZT https://ift.tt/2EyMZZT https://ift.tt/2TcgKIb

https://ift.tt/2EyMZZT Submitted February 27, 2019 at 05:17AM by madazzahatter https://ift.tt/2TcgKIb madazzahatter
Post a Comment
Read more